Sumpatan, Evelyn D.
HRN: 08-18-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/10/2023
CEFTRIAXONE 1G (VIAL)
12/10/2023
12/17/2023
IV
2g
Q24
Cap Mr
Checking Final Appropriateness
Indication: Empiric Type of Infection: PneumoniaProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes